These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 6129142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.
    Greefhorst AP, van Herwaarden CL.
    Eur J Clin Pharmacol; 1983; 24(2):173-8. PubMed ID: 6132819
    [Abstract] [Full Text] [Related]

  • 3. Failure of beta-adrenergic stimulation to affect cholecystokinin-stimulated sigmoid motility in man.
    Lyrenäs E, Abrahamsson H, Dotevall G.
    Scand J Gastroenterol; 1985 Dec; 20(10):1169-74. PubMed ID: 2869574
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rectosigmoid motility response to beta-adrenoceptor stimulation in patients with the irritable bowel syndrome.
    Lyrenäs E, Abrahamsson H, Dotevall G.
    Scand J Gastroenterol; 1985 Dec; 20(10):1163-8. PubMed ID: 2869573
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of xamoterol (ICI 118,587) in asthmatic patients.
    Löfdahl CG, Svedmyr N.
    Br J Clin Pharmacol; 1984 Oct; 18(4):597-601. PubMed ID: 6148960
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A, Klein G, Bibra HV, Sauer E.
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Beta adrenergic influence on esophageal and colonic motility in man.
    Lyrenäs E.
    Scand J Gastroenterol Suppl; 1985 Jan; 116():1-48. PubMed ID: 2864739
    [Abstract] [Full Text] [Related]

  • 13. Interaction in healthy volunteers between prenalterol, a selective beta 1-adrenoceptor agonist, and metoprolol or propranolol.
    Rönn O, Johnsson G, Lundborg P.
    J Cardiovasc Pharmacol; 1981 Jan; 3(3):477-84. PubMed ID: 6168829
    [Abstract] [Full Text] [Related]

  • 14. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA, Oltmanns D.
    Acta Med Scand Suppl; 1982 Jan; 659():181-90. PubMed ID: 6127888
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.
    Rönn O, Fellenius E, Graffner C, Johnsson G, Lundborg P, Svensson L.
    Eur J Clin Pharmacol; 1980 Feb; 17(2):81-6. PubMed ID: 6102914
    [Abstract] [Full Text] [Related]

  • 18. Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
    Löfdahl CG, Bengtsson B, Svedmyr K, Svedmyr N.
    Allergy; 1982 Jul; 37(5):351-7. PubMed ID: 6127039
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.